Tate & Lyle reported a 3% fall in group revenue to £1.02 billion for the six months ending 30 September 2025, citing softer market conditions and pricing pressures across key regions. The company said its recently integrated operations with CP Kelco are showing early signs of progress, with increased customer engagement and a broader innovation pipeline in sweetening, mouthfeel, and fortification ingredients.
The merger, which took effect in April 2025, aims to strengthen Tate & Lyle’s position in the food and beverage reformulation market, particularly as manufacturers pursue health, nutrition, and sustainability goals. To support growth, the group announced a series of targeted investments, including the expansion of its applications, nutrition science, and process development teams, alongside new digital and AI-driven tools worth around £8 million.
Operational improvements are also being prioritised, with a five-year productivity savings target raised to $200 million by March 2028. Regional performance remained mixed: the Americas saw a 2% revenue decline amid weaker beverage, bakery, and snack demand; EMEA sales fell 6% due to pricing pressures and reduced volumes; while Asia Pacific achieved stable growth and a 19% increase in adjusted EBITDA through cost efficiencies.